Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Peg Horn - Chief Operating Officer Mark Goldsmith - Chairman & Chief Executive Officer Steve Kelsey - President of R&D Jack Anders - Senior Vice President, Finance and Principal Accounting Officer Conference Call Participants Jonathan Chang - SVB Leerink Marc Frahm - Cowen & Company Operator Good day, ladies and gentlemen, and welcome to the Revolution Medicines Fourth Quarter and Ful ...

On Target to Outsmart Cancer TM A N U A RY 1 , 2 0 2 2 Legal Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, prospective products, availability of funding, ability to maintain existing collaborations, including with Sanofi, and est ...

Translating Frontier | --- | --- | --- | |---------------------|-------|-------| | | | | | Oncology Targets to | | | © 2021 Revolution Medicines Legal Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, prospective products, availabili ...

Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Peg Horn - Chief Operating Officer Mark Goldsmith - Chairman & Chief Executive Officer Jack Anders - Senior Vice President of Finance & Principal Accounting Officer Steve Kelsey - President of R&D Conference Call Participants Michael Schmidt - Guggenheim Jonathan Chang - SVB Leerink Eric Joseph - JPMorgan Marc Frahm - Cowen & Company Chris Shibutani - Goldman Sachs Benjamin Burnett ...

Revolution Medicines, Inc. (NASDAQ:RVMD) Q2 2021 Results Conference Call August 11, 2021 4:30 PM ET Company Participants Peg Horn - Chief Operating Officer Dr. Mark Goldsmith - Chairman and Chief Executive Officer Dr. Steve Kelsey - President Research and Development Jack Anders - Senior Vice President of Finance and Principal Accounting Officer Conference Call Participants Chris Shibutani - Goldman Sachs Marc Frahm - Cowen Michael Schmidt - Guggenheim Eric Joseph - JPMorgan Faisal Khurshid - SVB Leerink Op ...

Translating Frontier Oncology Targets to Outsmart Cancer™ Corporate Overview Q1 2021 March 2, 2021 © 2021 Revolution Medicines Legal Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, prospective products, availability of funding, abi ...